Author: Woo, Stephanie M; Davis, William D; Aggarwal, Soorya; Clinton, Joseph W; Kiparizoska, Sara; Lewis, James H
Title: Herbal and dietary supplement induced liver injury: Highlights from the recent literature Cord-id: byn3aqf0 Document date: 2021_9_27
ID: byn3aqf0
Snippet: Herbal-induced liver injury (HILI) is an important and increasingly concerning cause of liver toxicity, and this study presents recent updates to the literature. An extensive literature review was conducted encompassing September 2019 through March 2021. Studies with clinically significant findings were analyzed and included in this review. We emphasized those studies that provided a causality assessment methodology, such as Roussel Uclaf Causality Assessment Method scores. Our review includes r
Document: Herbal-induced liver injury (HILI) is an important and increasingly concerning cause of liver toxicity, and this study presents recent updates to the literature. An extensive literature review was conducted encompassing September 2019 through March 2021. Studies with clinically significant findings were analyzed and included in this review. We emphasized those studies that provided a causality assessment methodology, such as Roussel Uclaf Causality Assessment Method scores. Our review includes reports of individual herbals, including Garcinia cambogia, green tea extract, kratom as well as classes such as performance enhancing supplements, Traditional Chinese medicine, Ayurvedic medicine and herbal contamination. Newly described herbals include ashwagandha, boldo, skyfruit, and ‘Thermo gun’. Several studies discussing data from national registries, including the United States Drug-Induced Liver Injury (DILI) Network, Spanish DILI Registry, and Latin American DILI Network were incorporated. There has also been a continued interest in hepatoprotection, with promising use of herbals to counter hepatotoxicity from anti-tubercular medications. We also elucidated the current legal conversation surrounding use of herbals by presenting updates from the Federal Drug Administration. The highlights of the literature over the past year indicate interest in HILI that will continue as the supplement industry in the United States grows.
Search related documents:
Co phrase search for related documents- abdominal discomfort and acute hepatitis present: 1
- abdominal discomfort and acute liver: 1
- abdominal discomfort and liver disease: 1
- abdominal discomfort and liver failure: 1
- abdominal discomfort and liver function: 1
- abdominal discomfort and liver injury: 1
- abdominal discomfort and liver transplantation: 1
- abdominal discomfort and low threshold: 1
Co phrase search for related documents, hyperlinks ordered by date